Swati K, Arfin S, Agrawal K, Jha S, Rajendran R, Prakash A
Med Oncol. 2025; 42(4):88.
PMID: 40032774
DOI: 10.1007/s12032-025-02639-y.
Li Y, Jiang Y, Tong R, Ding B, Ge J, Du K
Transl Oncol. 2025; 54:102327.
PMID: 39986191
PMC: 11904789.
DOI: 10.1016/j.tranon.2025.102327.
Yu Y, Zhu C, Wang X, Shi Y, Gao Y, Yu Z
Front Pharmacol. 2025; 16:1545300.
PMID: 39917621
PMC: 11799564.
DOI: 10.3389/fphar.2025.1545300.
Grosu I, Constantinescu A, Balta M, Bajenaru O, Nuta C, Pavel C
Nutrients. 2024; 16(23).
PMID: 39683479
PMC: 11643276.
DOI: 10.3390/nu16234085.
Tian Y, Hu X, Wang X, Huang Y, Hao J, Guo Y
Discov Oncol. 2024; 15(1):732.
PMID: 39614999
PMC: 11608201.
DOI: 10.1007/s12672-024-01625-6.
PLEKHA4 upregulation regulates KIRC cell proliferation through β‑catenin signaling.
Yue Y, An G, Cao S, Li X, Du L, Xu D
Mol Med Rep. 2024; 31(1).
PMID: 39540374
PMC: 11582527.
DOI: 10.3892/mmr.2024.13395.
The conformation of FOXM1 homodimers in vivo is crucial for regulating transcriptional activities.
Hsu C, Yao X, Chen S, Tsuo T, Wang I
Nucleic Acids Res. 2024; 52(22):13625-13643.
PMID: 39535028
PMC: 11662942.
DOI: 10.1093/nar/gkae988.
Emerging roles and biomarker potential of WNT6 in human cancers.
Ferreira J, Goncalves C, Costa B
Cell Commun Signal. 2024; 22(1):538.
PMID: 39529066
PMC: 11552340.
DOI: 10.1186/s12964-024-01892-4.
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.
Sudalagunta P, Canevarolo R, Meads M, Silva M, Zhao X, Cubitt C
Cancer Res. 2024; 85(2):378-398.
PMID: 39476082
PMC: 11733535.
DOI: 10.1158/0008-5472.CAN-24-0886.
Novel benzothiazole/benzothiazole thiazolidine-2,4-dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies.
Abusharkh K, Comert Onder F, Cinar V, Onder A, Sikik M, Hamurcu Z
Arch Pharm (Weinheim). 2024; 357(12):e2400504.
PMID: 39318080
PMC: 11610698.
DOI: 10.1002/ardp.202400504.
Senescent lung-resident mesenchymal stem cells drive pulmonary fibrogenesis through FGF-4/FOXM1 axis.
Liu Y, Ji J, Zheng S, Wei A, Li D, Shi B
Stem Cell Res Ther. 2024; 15(1):309.
PMID: 39289765
PMC: 11409797.
DOI: 10.1186/s13287-024-03866-2.
Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis.
Liu K, Gao Q, Jia Y, Wei J, Chaudhuri S, Wang S
iScience. 2024; 27(9):110592.
PMID: 39246448
PMC: 11378969.
DOI: 10.1016/j.isci.2024.110592.
ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability.
Dong Q, Wang D, Song C, Gong C, Liu Y, Zhou X
Cell Death Differ. 2024; 31(10):1285-1301.
PMID: 39060421
PMC: 11445503.
DOI: 10.1038/s41418-024-01339-w.
Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression.
Liang L, Cai T, Li X, An J, Yu S, Zhang Y
Genes Dis. 2024; 11(5):101203.
PMID: 39022126
PMC: 11252794.
DOI: 10.1016/j.gendis.2023.101203.
A cuproptosis-related gene DLAT as a novel prognostic marker and its relevance to immune infiltration in low-grade gliomas.
Gao P, Li H, Qiao Y, Nie J, Cheng S, Tang G
Heliyon. 2024; 10(11):e32270.
PMID: 38961981
PMC: 11219321.
DOI: 10.1016/j.heliyon.2024.e32270.
Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.
Wu L, Zhao Z, Shin Y, Yin Y, Raju A, Vaiyapuri T
Nat Cell Biol. 2024; 26(6):1003-1018.
PMID: 38858501
PMC: 11178504.
DOI: 10.1038/s41556-024-01428-5.
Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA.
Chen M, Zhu H, Li J, Luo D, Zhang J, Liu W
Ann Med. 2024; 56(1):2282184.
PMID: 38738386
PMC: 11095293.
DOI: 10.1080/07853890.2023.2282184.
NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells.
Liu C, Vorderbruggen M, Munoz-Trujillo C, Kim S, Katzenellenbogen J, Katzenellenbogen B
J Ovarian Res. 2024; 17(1):94.
PMID: 38704607
PMC: 11069232.
DOI: 10.1186/s13048-024-01421-4.
Glioma Stem Cells-Features for New Therapy Design.
Pecina-Slaus N, Hrascan R
Cancers (Basel). 2024; 16(8).
PMID: 38672638
PMC: 11049195.
DOI: 10.3390/cancers16081557.
NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.
Wu R, Sun C, Chen X, Yang R, Luan Y, Zhao X
Proc Natl Acad Sci U S A. 2024; 121(14):e2321611121.
PMID: 38547058
PMC: 10998593.
DOI: 10.1073/pnas.2321611121.